DrugSupplement
Equol clinical trials
Also written AUS-131.
- studies test it
- 13
- open now
- 2
- in phase 3
- 0
- first study started
- 2008
Keep track of what changes. Save the Equol studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Combined with it in one product
Studies by the year they started
13 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2019 | 1 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 4
- Phase 2
- 6
- No phase
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 7
Ausio Pharmaceuticals, LLC (4) · University of Reading (2) · University of Colorado, Denver (2) · Akira Sekikawa (1) · Pharmavite LLC (1) · The University of Texas Health Science Center at San Antonio (1) · Russell Swerdlow, MD (1) · Nexgen Dermatologics, Inc. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Equol is read from its arms, and is right about nine times in ten.
Testing it · 13
- Equol and Vascular Function in Women With Chronic Kidney DiseaseRecruitingPhase 2University of Colorado, DenverNCT07194590Written as Equol
- Acute Equol Supplementation and Vascular Function in Women With and Without CKDRecruitingPhase 2University of Colorado, DenverNCT06128278Written as S-equol
- Effect of Equol Supplementation on Arterial Stiffness and Cognition in Healthy VolunteersActive, not recruitingPhase 2Akira SekikawaNCT05741060Written as S-equol
- Genistein, Equol, Cognitive Function and Mood: Acute. (GECFAMa)CompletedNot applicableUniversity of ReadingNCT07742514Written as Equol
- Genistein, Equol, Cognitive Function and Mood: Twelve-week. (GECFAMc)CompletedNot applicableUniversity of ReadingNCT07742501Written as Equol
- A Nutritional Supplement on Vasomotor Symptoms in WomenCompletedNot applicablePharmavite LLCNCT04516304Written as S-equol
- S-equol in Women With Triple Negative Breast CancerCompletedEarly Phase 1The University of Texas Health Science Center at San AntonioNCT02352025Written as S-equol
- Efficacy and Safety of S-Equol on Men With Benign Prostatic HyperplasiaCompletedPhase 2Ausio Pharmaceuticals, LLCNCT00962390Written as S-equol
- S-Equol in Alzheimer's Disease (SEAD) TrialCompletedPhase 1Russell Swerdlow, MDNCT02142777Written as S -Equol
- Efficacy and Safety of S-equol on Vasomotor Symptoms in Menopausal PatientsCompletedPhase 2Ausio Pharmaceuticals, LLCNCT00962585Written as S-equol
- Multi-Dose Safety and Pharmacokinetic Study of S-Equol in Healthy VolunteersCompletedPhase 1Ausio Pharmaceuticals, LLCNCT00998920Written as S-equol
- Safety and Pharmacokinetic Study of S-Equol in Healthy VolunteersCompletedPhase 1Ausio Pharmaceuticals, LLCNCT00787007Written as S-equol
- A Novel Combination Oral Agent to Treat Acne VulgarisStatus unknownPhase 1/2Nexgen Dermatologics, Inc.NCT01301586Written as Doxycycline and S-equol
Codes
What other systems call Equol · ClinicalTrials.gg INT008943
- MeSH (NLM) D060754EquolConfirmed ClinicalTrials.gov, Wikidata
- UNII (FDA) 2T6D2HPX7QEQUOLConfirmed FDA, Wikidata
- RxNorm 1803717Confirmed FDA, Wikidata
- Wikidata Q5384747(-)-equolConfirmed FDA, Wikidata
- NCI Thesaurus C120313S-equolConfirmed FDA, Wikidata
- DrugBank DB11674One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D060754 | Equol | Confirmed ClinicalTrials.gov, Wikidata |
| UNII (FDA) | 2T6D2HPX7Q | EQUOL | Confirmed FDA, Wikidata |
| RxNorm | 1803717 | — | Confirmed FDA, Wikidata |
| Wikidata | Q5384747 | (-)-equol | Confirmed FDA, Wikidata |
| NCI Thesaurus | C120313 | S-equol | Confirmed FDA, Wikidata |
| DrugBank | DB11674 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.